Procedural· Chapter 30

Colonoscopy Practice and Quality

USPSTF age-45 screening, ADR and withdrawal-time benchmarks, the bowel-prep choice cascade (split-dose, low-volume, hyperosmolar), USMSTF post-polypectomy surveillance intervals, and the polyp resection technique decision tree from cold snare through EMR to ESD.

60 MCQs
  • Audio chapter
    Attending-narrated, listen on the commute.
  • ABIM-format MCQs
    5-option vignettes with full wrong-answer teaching.
  • Study guide
    Tables, decision trees, primary sources.
  • AI tutor
    Chapter-grounded, answers the question you're stuck on.

What this chapter covers

  • Section 30.1: CRC screening modalities and USPSTF age update

    Colorectal cancer screening exists because the disease has a long, recognizable precursor lesion and a survivable early stage, and the modality menu is engineered to give every patient a route in.

  • Section 30.2: Bowel preparation and procedural quality foundations

    Bowel preparation adequacy is the foundation on which every subsequent quality metric rests, because inadequate preparation roughly doubles polyp miss rates and detection technique cannot compensate for residual stool obscuring mucosa.

  • Section 30.3: Detection metrics: ADR, SSLDR, withdrawal

    Adenoma detection rate is the single most validated quality metric in colonoscopy because its association with interval cancer is robust across populations.

  • Section 30.4: Polyp recognition and morphology

    Polyp morphology drives both cancer risk assessment and resection technique selection, because morphology reflects the underlying growth pattern that determines whether a lesion has invaded vertically into the submucosa or spread horizontally along the mucosa.

  • Section 30.5: Resection technique selection

    Resection technique is selected by polyp size, morphology, and cancer-risk features.

  • Section 30.6: Malignant polyp management

    Pathology terminology in colorectal lesions is confusing and clinically consequential, and the principle that drives all malignant polyp management is that submucosal invasion, not mucosal involvement, is what carries metastatic potential.

  • Section 30.7: 2020 USMSTF post-polypectomy surveillance intervals

    The 2020 US Multi-Society Task Force update on follow-up after colonoscopy and polypectomy drives interval selection from index findings, and the principle behind interval selection is that the likelihood of metachronous advanced neoplasia within the surveillance window is calibrated to the highest-risk lesion at the index colonoscopy.

  • Section 30.8: Post-polypectomy adverse events

    Post-polypectomy adverse events are recognizable, gradable, and largely manageable when caught early, and each event has a specific anatomic or thermal mechanism that determines management.

  • Section 30.9: The serrated pathway and Lynch sorting

    The serrated pathway accounts for 15 to 30 percent of colorectal cancers and travels a molecular route distinct from the conventional adenoma-carcinoma sequence.

  • Section 30.10: Special-population colonoscopy

    Special populations modify all four phases of colonoscopy (preparation, sedation, intervention, recovery), and the boards test the modifications as patient-specific deviations from the standard algorithm rather than as separate procedures.

Podcast episodes

  1. 01

    Screening Quality Detection

    This episode covers CRC screening, bowel preparation, and the detection metrics that define colonoscopy quality: USPSTF age forty-five for average-risk screening with the modality menu, split-dose preparation with Boston Bowel Preparation Scale adequacy, cecal intubation rates, and the adenoma detection rate that is the strongest predictor of interval...

  2. 02

    Polyp Recognition and Resection

    This episode covers polyp recognition and resection technique: Paris morphology classification, NICE and JNET endoscopic prediction, Kudo pit pattern, the lateral spreading granularity types, and resection technique selection by size and morphology, with cold snare for small polyps and EMR for larger lesions.

  3. 03

    Malignant Polyp and Surveillance

    This episode covers the malignant polyp and post-polypectomy surveillance: the anatomic rule that makes the muscularis mucosae the line that matters, the Kikuchi and Haggitt depth systems, the high-risk histologic features including ITBCC tumor budding, and the USMSTF twenty twenty surveillance intervals.

  4. 04

    Adverse Events

    This episode covers the post-polypectomy adverse events: delayed and immediate bleeding, the prophylactic-clip question, perforation and its closure decision, post-polypectomy electrocoagulation syndrome, and splenic injury.

  5. 05

    Serrated Lynch Special

    This episode covers the serrated pathway and Lynch testing and special- population colonoscopy: sessile serrated lesion biology with the WHO twenty nineteen two-criterion serrated polyposis syndrome definition, the Lynch reflex testing pathway with MMR immunohistochemistry and MLH1 promoter methylation, and special populations including IBD...